ATE187068T1 - Mikrogranulate enthaltend 5-nitroimidazolderivate - Google Patents

Mikrogranulate enthaltend 5-nitroimidazolderivate

Info

Publication number
ATE187068T1
ATE187068T1 AT95907683T AT95907683T ATE187068T1 AT E187068 T1 ATE187068 T1 AT E187068T1 AT 95907683 T AT95907683 T AT 95907683T AT 95907683 T AT95907683 T AT 95907683T AT E187068 T1 ATE187068 T1 AT E187068T1
Authority
AT
Austria
Prior art keywords
microgranules
medicinal
nitroimidazole derivatives
microgranules containing
hand
Prior art date
Application number
AT95907683T
Other languages
German (de)
English (en)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Application granted granted Critical
Publication of ATE187068T1 publication Critical patent/ATE187068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95907683T 1994-01-14 1995-01-12 Mikrogranulate enthaltend 5-nitroimidazolderivate ATE187068T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.

Publications (1)

Publication Number Publication Date
ATE187068T1 true ATE187068T1 (de) 1999-12-15

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907683T ATE187068T1 (de) 1994-01-14 1995-01-12 Mikrogranulate enthaltend 5-nitroimidazolderivate

Country Status (19)

Country Link
JP (1) JPH09507499A (pl)
KR (1) KR100320140B1 (pl)
CN (1) CN1088357C (pl)
AT (1) ATE187068T1 (pl)
AU (1) AU705570B2 (pl)
BR (1) BR9506507A (pl)
CZ (1) CZ286080B6 (pl)
DE (1) DE69513632T2 (pl)
DK (1) DK0739201T3 (pl)
ES (1) ES2139883T3 (pl)
MA (1) MA23429A1 (pl)
MX (1) MX9602772A (pl)
NZ (1) NZ279238A (pl)
OA (1) OA10583A (pl)
PL (1) PL178424B1 (pl)
PT (1) PT739201E (pl)
RU (1) RU2152212C1 (pl)
SK (1) SK282066B6 (pl)
UA (1) UA28031C2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
RU2220711C1 (ru) * 2002-04-24 2004-01-10 Закрытое акционерное общество "Брынцалов-А" Противомикробное и противопротозойное средство "трихоброл"
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
EP3721871A1 (de) 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346095A (en) * 1978-02-10 1982-08-24 Mercer James B Therapeutic treatment for viral hepatitis infection
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
DE69131574T2 (de) * 1990-05-14 2000-05-04 Gary R. Jernberg Chirurgisches implantat und verfahren zum einbetten von chemotherapeutika
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.

Also Published As

Publication number Publication date
DK0739201T3 (da) 2000-05-01
DE69513632D1 (de) 2000-01-05
SK282066B6 (sk) 2001-10-08
CZ286080B6 (cs) 2000-01-12
PL178424B1 (pl) 2000-04-28
PL315530A1 (en) 1996-11-12
SK91496A3 (en) 1996-12-04
ES2139883T3 (es) 2000-02-16
UA28031C2 (uk) 2000-10-16
BR9506507A (pt) 1997-09-09
OA10583A (en) 2002-07-10
DE69513632T2 (de) 2000-04-06
MA23429A1 (fr) 1995-10-01
CN1088357C (zh) 2002-07-31
AU705570B2 (en) 1999-05-27
KR100320140B1 (ko) 2002-07-02
CN1138826A (zh) 1996-12-25
MX9602772A (es) 1997-05-31
NZ279238A (en) 1998-03-25
RU2152212C1 (ru) 2000-07-10
AU1580395A (en) 1995-08-01
CZ205596A3 (en) 1996-10-16
JPH09507499A (ja) 1997-07-29
PT739201E (pt) 2000-05-31

Similar Documents

Publication Publication Date Title
MX9707334A (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
DE69829008D1 (de) Nasen-, Mund- und Rachenraumkanüle
ID21115A (id) Isokuinolin-3-karboksamida tersubstitusi, pembuatannya serta penggunaannya sebagai obat
TR199800602A3 (tr) Dithiolan türevleri, hazirlanmalari ve terapötik etkileri.
FR15C0024I2 (fr) Indolinones substituees en position 6, leur preparation et leur utilisation en tant que medicaments
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
DE60023107D1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
HUP0200710A3 (en) Benzimidazoles, production thereof and use thereof as medicaments
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
ES2139883T3 (es) Microgranulos de derivados de 5-nitroimidazol.
IT1299197B1 (it) Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
EP0672052A1 (en) TACHYQUININE ANTAGONISTS, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
EA199900963A1 (ru) Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
RU2000105740A (ru) Лечебное средство при отравлении животных кадмием, свинцом и ртутью
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates
SK2502U (sk) Obálka s doručenkou
TR28011A (tr) Aritilmis/saf streptogramin ve hazirlanisi.
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee